Iranian
Biomedical Journal
Volume 30, Issue 2 (Supplementary 2026)
IBJ 2026, 30(2): 41-41 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tehranian A, Farasati Far B, Nahavandi R. Metal-Organic Frameworks as Next-Generation Platforms for Cardiac Regeneration: Advancing Plasma-Enabled Biofunctionalization. IBJ 2026; 30 (2) :41-41
URL: http://ibj.pasteur.ac.ir/article-1-5544-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5544-en.html
Abstract:
Introduction: Cardiovascular diseases remain the leading global cause of mortality, with the adult human heart exhibiting minimal regenerative capacity after myocardial infarction (MI). Metal-organic frameworks (MOFs) have emerged as highly promising multifunctional platforms in cardiac tissue engineering due to their ultra-high surface area, tunable porosity, and capabilities as scaffolds, coatings, and controlled-release carriers. This study comprehensively reviews the potential of MOFs in cardiac regeneration, with particular emphasis on their readiness for next-generation surface modification techniques.
Materials and Methods: We conducted a systematic literature review (2010–2024) across databases such as PubMed, Scopus, and Web of Science. Keywords included “metal-organic frameworks”, “MOFs”, “cardiac regeneration”, “myocardial infarction”, and “drug delivery”. The review concentrated on Zr-, Zn-, and Fe-based MOFs (UiO-66, ZIF-8, MIL-series, PCN-333), their synthesis routes, surface functionalization strategies, biocompatibility assays, and preclinical cardiac models (rodent MI, zebrafish). Special attention was given to MOF systems that can undergo post-synthesis modification, including plasma-based surface activation.
Results: MOFs demonstrated excellent cytocompatibility (>92% cardiomyocyte viability), sustained release of growth factors/miRNAs, enhanced angiogenesis, reduced fibrosis, and up to 68% infarct size reduction in rodent models. The abundant surface functional groups and thermal/chemical stability of MOFs render them ideal substrates for cold-plasma treatment, plasma polymerization, and plasma-induced grafting techniques, which have been proven to improve protein adsorption, cell adhesion, and anti-thrombogenic properties.
Conclusion: MOFs are a versatile, clinically translatable platform for cardiac repair. Their inherent structural advantages, combined with their readiness for plasma-mediated surface biofunctionalization, position them as next-generation materials capable of addressing proliferation, vascularization, and immunological barriers in post-MI regeneration.
Materials and Methods: We conducted a systematic literature review (2010–2024) across databases such as PubMed, Scopus, and Web of Science. Keywords included “metal-organic frameworks”, “MOFs”, “cardiac regeneration”, “myocardial infarction”, and “drug delivery”. The review concentrated on Zr-, Zn-, and Fe-based MOFs (UiO-66, ZIF-8, MIL-series, PCN-333), their synthesis routes, surface functionalization strategies, biocompatibility assays, and preclinical cardiac models (rodent MI, zebrafish). Special attention was given to MOF systems that can undergo post-synthesis modification, including plasma-based surface activation.
Results: MOFs demonstrated excellent cytocompatibility (>92% cardiomyocyte viability), sustained release of growth factors/miRNAs, enhanced angiogenesis, reduced fibrosis, and up to 68% infarct size reduction in rodent models. The abundant surface functional groups and thermal/chemical stability of MOFs render them ideal substrates for cold-plasma treatment, plasma polymerization, and plasma-induced grafting techniques, which have been proven to improve protein adsorption, cell adhesion, and anti-thrombogenic properties.
Conclusion: MOFs are a versatile, clinically translatable platform for cardiac repair. Their inherent structural advantages, combined with their readiness for plasma-mediated surface biofunctionalization, position them as next-generation materials capable of addressing proliferation, vascularization, and immunological barriers in post-MI regeneration.
 |
Keywords: Cardiac regeneration, Controlled drug delivery, Myocardial infarction, Metal-organic frameworks, Plasma surface modification
Type of Study: Congress |
Subject:
Related Fields
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |